08:00 , Dec 18, 2000 |  BC Week In Review  |  Company News

Agritope, Exelixis deal

EXEL completed its previously announced acquisition of Agritope for 1.7 million EXEL shares, valuing Agritope at $27 million based on EXEL’s Friday close of $15.875 (see BioCentury, Sept. 11). Agritope Inc. , Portland, Ore.  ...
07:00 , Oct 23, 2000 |  BC Week In Review  |  Company News

Agritope other research news

AGTO received a $265,000 Phase II SBIR grant from the U.S. Department of Agriculture to develop transgenic raspberry plants resistant to RBDV. AGTO is being acquired by functional genomics company Exelixis Inc. (EXEL, South San...
07:00 , Sep 18, 2000 |  BC Week In Review  |  Company News

Agritope, Rohm and Haas Co. deal

The companies will develop a plant transformation marker selection system using AGTO's visual marker plant gene technology and ROH's ecdysone receptor-based ligand-inducible gene expression technology. ROH will manufacture the gene expression regulating ligand and market...
07:00 , Sep 14, 2000 |  BC Extra  |  Company News

Agritope plant transformation deal with Rohm and Haas

The companies will combine AGTO's visual marker gene technology with ROH's ligand-inducible gene expression technology to develop a plant transformation marker selection system. ROH will contribute its synthetic ecdysone receptors and ligand inducer chemistry for...
07:00 , Sep 11, 2000 |  BC Week In Review  |  Company News

Agritope, Exelixis deal

EXEL will acquire AGTO, an agricultural functional genomics company, in a stock transaction. AGTO shareholders will receive between 0.28 and 0.35 EXEL shares for each share of AGTO common and preferred stock held. The transaction...
07:00 , Sep 7, 2000 |  BC Extra  |  Company News

Exelixis to acquire Agritope

The companies entered into a definitive agreement for EXEL to acquire AGTO, an agricultural functional genomics company, in a stock transaction. AGTO shareholders will receive between 0.28 and 0.35 EXEL shares for each share of...
07:00 , Jul 10, 2000 |  BC Week In Review  |  Clinical News

RE4 plant gene promoter regulatory update

AGTO received U.S. Patent No. 6,054,635 covering a plant gene promoter derived from raspberries. The company said that RE4 can control gene activity in many or all tissues from a number of plant species, AGTO...
07:00 , Jun 26, 2000 |  BC Week In Review  |  Company News

Agrinomics LLC, Genopsis deal

Genopsis, a joint venture between Vilmorin Clause & Cie (Chappes, France) and Biotech M.A.H. Plant Genomic Fund (Tel Aviv, Israel), will pay Agrinomics $7.5 million over five years to use Agrinomics' ACTTAG technology to discover...
07:00 , Jun 19, 2000 |  BC Week In Review  |  Company News

Agritope other research news

AGTO received a $70,000 Phase I SBIR grant from the U.S. Department of Agriculture to develop plants resistant to whitefly-transmitted viruses. AGTO has an option to license the resistance technology from Ohio State University (Columbus,...
07:00 , Jun 5, 2000 |  BC Week In Review  |  Clinical News

Superbrassinolide synthetic plant growth hormones regulatory update

AGTO received U.S. Patent No. 6,063,731 covering the use of synthetic analogs of naturally occurring brassinolide plant growth hormones, called superbrassinolides, to promote plant growth. AGTO has an option to exclusively license the compounds from...